Episode 308: Neal and Toby dive into Tesla’s Q1 earnings report which certainly had its ups and downs with the announcement of a new affordable model despite having an abysmal sales performance. Then, the FTC just banned noncompete agreements because it believes it could raise the earnings of Americans. Next, Meta just released its chat bot and wants to make sure everyone knows about it. Meanwhile, there could be a new miracle drug that is a fraction of the cost of Ozempic. Also, a Finnish company wants to solve the world’s coffee supply problem with AI. Lastly, Armand Duplantis breaks his own pole vaulting record and there’s a cash incentive why. 

00:00 - Intro

2:45 - Tesla’s optimistic future

7:00 - FTC bans noncompete agreements

10:30 - Meta AI is here

13:45 - Newest miracle drug for cheap?

18:00 - Cup of AI joe

21:00 - Pole vault your incentives

Get your Morning Brew Daily Merch HERE: https://shop.morningbrew.com/products/morning-brew-daily-sweatshirt?utm_medium=multimedia&utm_source=podcast&utm_campaign=mbd&utm_content=shownotes

Listen to Morning Brew Daily Here: https://link.chtbl.com/MBD

Watch Morning Brew Daily Here: https://www.youtube.com/@MorningBrewDailyShow

Learn more about your ad choices. Visit megaphone.fm/adchoices

Podden och tillhörande omslagsbild på den här sidan tillhör Morning Brew. Innehållet i podden är skapat av Morning Brew och inte av, eller tillsammans med, Poddtoppen.